| Date Filed | Type | Description |
| 10/03/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 448 shares
@ $27.88, valued at
$12.5k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 6,020 shares
@ $32.02, valued at
$192.8k
Exercised 6,020 options to buy
@ $6.72, valued at
$40.5k
|
|
| 07/05/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 374 shares
@ $33.36, valued at
$12.5k
|
|
| 05/18/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $37.89, valued at
$378.9k
|
|
| 04/05/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 298 shares
@ $37.71, valued at
$11.2k
|
|
| 02/08/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 7,000 shares
@ $45, valued at
$315k
Exercised 7,000 options to buy
@ $6.72, valued at
$47k
|
|
| 01/04/2023 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 253 shares
@ $44.35, valued at
$11.2k
|
|
| 10/05/2022 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 110 shares
@ $51.11, valued at
$5.6k
|
|
| 09/01/2022 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 4,166 shares
@ $52.79, valued at
$219.9k
Exercised 4,166 options to buy
@ $6.78, valued at
$28.2k
|
|
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $18.29, valued at
$320.1k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 146 shares
@ $38.38, valued at
$5.6k
|
|
| 01/04/2022 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 122 shares
@ $46, valued at
$5.6k
|
|
| 12/28/2021 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 4,166 shares
@ $44.3721, valued at
$184.9k
Exercised 4,166 options to buy
@ $5.46, valued at
$22.7k
|
|
| 10/04/2021 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 306 shares
@ $36.74, valued at
$11.2k
|
|
| 07/08/2021 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 63 shares
@ $19.77, valued at
$1.2k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2020 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 3,333 shares
@ $16, valued at
$53.3k
Sold 6,666 shares
@ $16, valued at
$106.7k
Exercised 3,333 options to buy
@ $8.64, valued at
$28.8k
Exercised 6,666 options to buy
@ $11.04, valued at
$73.6k
|
|
| 04/29/2020 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Exercised 25,329 options to buy
@ $0.73, valued at
$18.5k
|
|
| 06/25/2019 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $23.24, valued at
$290.5k
|
|
| 05/17/2019 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 20,000 options to buy
@ $10.68, valued at
$213.6k
|
|
| 07/17/2018 |
3
| WIERENGA WENDALL (Director) has filed a Form 3 on Crinetics Pharmaceuticals, Inc. |
| 06/18/2018 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $19.59, valued at
$195.9k
|
|
| 05/17/2018 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 20,000 options to buy
@ $9.45, valued at
$189k
|
|
| 01/08/2018 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.11, valued at
$73.9k
|
|
| 01/04/2018 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 5,714 options to buy
@ $8.75, valued at
$50k
|
|
|